Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

Are you wondering whether you’re a candidate for one of the newer weight-loss drugs, semaglutide (Wegovy ... Center at Weill Cornell Medicine in New York City. This helps control blood sugar.

Another big one is muscle loss. A new ... weight loss,” Gerhart-Hines said. He explained that GLP-1 agonists don’t work quite as well for weight loss in people with diabetes because the drug ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares.

Health News // 1 week ago FDA approves weight-loss drug Zepbound to treat sleep apnea Dec. 21 (UPI) -- Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food ...

Novo Nordisk (NYSE:NVO)'s new weight loss drug CagriSema missed the company's target of reducing at least 25% body weight of the Phase 3 trials' participants. CagriSema only showed an average 22.7 ...